GOGVHD FUND

In partnership with all major Chicago research universities (Northwestern, Loyola, University of Chicago and Rush University), we have established an interdisciplinary conference on ocular GVHD that is funded by the National Eye Institute/NIH. This conference helps to bridge numerous gaps, not only between ophthalmologists and hematologists/ oncologists, but also between medical centers within and outside of the Chicagoland area, and basic scientists and clinicians. The conference brings nationally recognized experts to Chicago to disseminate new findings in the area of chronic GVHD and fosters discussions amongst physicians, nurses, residents and medical students covering clinical, research and educational challenges and opportunities... Patients with ocular GVHD deserve the most effective ways to diagnose and treat the disease. Currently, there are no approved treatments for ocular GVHD, therefore, many novel therapies require compounding by an onsite pharmacy. Because these are..

Primary location: Chicago United States